A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models

BACKGROUND Nonadherence to a physician-prescribed therapeutic intervention is a costly, dangerous, and sometimes fatal concern in healthcare. To date, the study of nonadherence has been constrained to clinical studies. The novel approach described herein allows for the preclinical study of nonadherence in etiologically relevant disease animal model systems. NEW METHOD The method herein describes a novel computer-automated pellet delivery system which allows for the study of nonadherence in animals. This system described herein allows for tight experimenter control of treatment using a drug-in-food protocol. Food-restricted animals receive either medicated or unmedicated pellets, designed to mimic either "taking" or "missing" a drug. RESULTS The system described permits the distribution of medicated or unmedicated food pellets on an experimenter-defined feeding schedule. The flexibility of this system permits the delivery of drug according to the known pharmacokinetics of investigational drugs. COMPARISON WITH OTHER METHODS Current clinical adherence research relies on medication-event monitoring system (MEMS) tracking caps, which allows clinicians to directly monitor patient adherence. However, correlating the effects of nonadherence to efficacy still relies on the accuracy of patient journals. CONCLUSION This system allows for the design of studies to address the impact of nonadherence in an etiologically relevant animal model. Given methodological and ethical concerns of designing clinical studies of nonadherence, animal studies are critical to better understand medication adherence. While the system described was designed to measure the impact of nonadherence on seizure control, it is clear that the utility of this system extends beyond epilepsy to include other disease states.

[1]  F. Dudek,et al.  Anticonvulsant Effects of Carbamazepine on Spontaneous Seizures in Rats with Kainate‐induced Epilepsy: Comparison of Intraperitoneal Injections with Drug‐in‐food Protocols , 2007, Epilepsia.

[2]  T. Glauser,et al.  Development and reliability of a correction factor for parent‐reported adherence to pediatric antiepileptic drug therapy , 2010, Epilepsia.

[3]  C. Elger,et al.  Epilepsy: accuracy of patient seizure counts. , 2007, Archives of neurology.

[4]  E. Faught Adherence to antiepilepsy drug therapy , 2012, Epilepsy & Behavior.

[5]  J. Rausch,et al.  Early pediatric antiepileptic drug nonadherence is related to lower long-term seizure freedom , 2014, Neurology.

[6]  Michel Bourin,et al.  Forced swimming test in mice: a review of antidepressant activity , 2004, Psychopharmacology.

[7]  John Weinman,et al.  Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review , 2013, Dementia and Geriatric Cognitive Disorders.

[8]  David M Cutler,et al.  Thinking outside the pillbox--medication adherence as a priority for health care reform. , 2010, The New England journal of medicine.

[9]  U. Bergman,et al.  Antidepressants, depression and suicide: an analysis of the San Diego study. , 1994, Journal of affective disorders.

[10]  H. Günthard,et al.  Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study , 2009, Journal of acquired immune deficiency syndromes.

[11]  Michael C. Smith,et al.  Medication management by the person with epilepsy: perception versus reality , 2004, Epilepsy & Behavior.

[12]  J. Rausch,et al.  Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. , 2011, JAMA.

[13]  R McCarthy,et al.  The price you pay for the drug not taken. , 1998, Business and health.

[14]  J. Cramer,et al.  How often is medication taken as prescribed? A novel assessment technique. , 1989, JAMA.

[15]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[16]  J. Cryan,et al.  The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice , 2005, Neuroscience & Biobehavioral Reviews.

[17]  P. D. De Deyn,et al.  Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease , 2008, Psychopharmacology.

[18]  Angelo Antonini,et al.  Adherence to antiparkinson medication in a multicenter European study , 2009, Movement disorders : official journal of the Movement Disorder Society.